Results 141 to 150 of about 15,268 (219)

Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing Murine Melanoma Cells. [PDF]

Pharmaceuticals (Basel), 2023
Correa-Lara MVM, Lara-Vega I, Nájera-Martínez M, Domínguez-López ML, Reyes-Maldonado E, Vega-López A.   +5 more
europepmc   +1 more source

CD1 and iNKT cells mediate immune responses against the GBS hemolytic lipid toxin induced by a non-toxic analog. [PDF]

PLoS Pathog, 2023
Furuta A, Coleman M, Casares R, Seepersaud R, Orvis A, Brokaw A, Quach P, Nguyen S, Sweeney E, Sharma K, Wallen G, Sanghavi R, Mateos-Gil J, Cuerva JM, Millán A, Rajagopal L.   +15 more
europepmc   +1 more source

Innate iNKT cells: from biological insight to clinical impact. [PDF]

Front Immunol
Rotolo A, Mason NJ, Exley MA.
europepmc   +1 more source

Expansion of iNKT Cells Promotes Liver Repair Following Hepatic Ischemia Reperfusion Injury. [PDF]

In Vivo, 2022
Goto T, Ito Y, Nishizawa N, Kuroda YU, Nakamoto S, Hosono K, Naitoh T, Hiki N, Amano H.   +8 more
europepmc   +1 more source

CAR-iNKT cells: redefining the frontiers of cellular immunotherapy. [PDF]

Front Immunol
Niedzielska M, Chalmers A, Popis MC, Altman-Sharoni E, Addis S, Beulen R, Rudqvist NP, Chantzoura E, Purbhoo MA, Chand D, Exley MA.   +10 more
europepmc   +1 more source

Allogeneic iPSC-derived iNKT cells in recurrent head and neck cancer: a phase 1 trial. [PDF]

Nat Commun
Iinuma T, Kurokawa T, Aoki T, Onodera A, Fukazawa T, Yamada D, Kitahara G, Okoshi M, Yamaguchi M, Okura H, Sasaki S, Sasako Y, Kira S, Sharif J, Tsuchiyama Y, Kobayashi M, Kobayashi N, Horikoshi T, Inaba Y, Hanaoka H, Okamoto Y, Hanazawa T, Koseki H, Motohashi S.   +23 more
europepmc   +1 more source

Early Activation of iNKT Cells Increased Survival Time of BALB/c Mice in a Murine Model of Melioidosis. [PDF]

Infect Immun, 2022
Kasetthat T, Kamuthachad L, Sermswan RW, Watarai H, Matangkasombut P, Wongratanacheewin S.   +5 more
europepmc   +1 more source

Global trends and frontiers in iNKT cells: a bibliometric and visualized analysis. [PDF]

Front Immunol
Zhang D, Lu J.
europepmc   +1 more source

Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment. [PDF]

Front Med (Lausanne), 2022
Delfanti G, Dellabona P, Casorati G, Fedeli M.   +3 more
europepmc   +1 more source

PRR enhances anti-tumor immunity and suppresses colitis by promoting the development and survival of naive T and iNKT cells. [PDF]

Front Immunol
Shimba A, Munakata S, Abe S, Cui G, Kato R, Miyazaki M, Ichihara A, Ikuta K.   +7 more
europepmc   +1 more source